PURPOSE: To emphasize a possible role of magnetic resonance (MR) diffusion-weighted imaging (DWI) for lesion conspicuity and detection of treatment effects in children with medulloblastoma. MATERIAL AND METHODS: Three children with medulloblastoma (two residual and one recurrent) were examined repetitively by MR diffusion-weighted imaging. Regional assessment of the apparent diffusion coefficient (ADC) was done for tumorous lesions and periventricular white matter appearing normal on standard MR images. RESULTS: All lesions were clearly visible on DWI. In the case of recurrent tumor, on one scan, DWI showed lesions that were not seen on contrast-enhanced MRI. Increase (41%) of ADC was seen in one lesion, which subsequently responded completely to treatment over 27 months' follow-up. Intermediate increases (23-26%) of ADC were found with partial therapy response in three lesions. In contrast, a decrease (-11%) of ADC in two lesions was seen with tumor progression. CONCLUSION: These observations may suggest a role for DWI in early detection of metastatic disease and treatment monitoring of medulloblastoma, warranting a formal study.
PURPOSE: To emphasize a possible role of magnetic resonance (MR) diffusion-weighted imaging (DWI) for lesion conspicuity and detection of treatment effects in children with medulloblastoma. MATERIAL AND METHODS: Three children with medulloblastoma (two residual and one recurrent) were examined repetitively by MR diffusion-weighted imaging. Regional assessment of the apparent diffusion coefficient (ADC) was done for tumorous lesions and periventricular white matter appearing normal on standard MR images. RESULTS: All lesions were clearly visible on DWI. In the case of recurrent tumor, on one scan, DWI showed lesions that were not seen on contrast-enhanced MRI. Increase (41%) of ADC was seen in one lesion, which subsequently responded completely to treatment over 27 months' follow-up. Intermediate increases (23-26%) of ADC were found with partial therapy response in three lesions. In contrast, a decrease (-11%) of ADC in two lesions was seen with tumor progression. CONCLUSION: These observations may suggest a role for DWI in early detection of metastatic disease and treatment monitoring of medulloblastoma, warranting a formal study.
Authors: Craig J Galbán; Stefanie Galbán; Marcian E Van Dort; Gary D Luker; Mahaveer S Bhojani; Alnawaz Rehemtulla; Brian D Ross Journal: Prog Mol Biol Transl Sci Date: 2010 Impact factor: 3.622
Authors: Inas S Khayal; Mei-Yin C Polley; Llewellyn Jalbert; Adam Elkhaled; Susan M Chang; Soonmee Cha; Nicholas A Butowski; Sarah J Nelson Journal: Neuro Oncol Date: 2010-05-25 Impact factor: 12.300
Authors: Dong-Liang Cheng; Wen-Sheng Wang; Yi-Xin Hu; Meng-Lin Chen; Ge Wen; Li-Na Cheng; Jing Wu; Liu-Qing Yan Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2017-01-20
Authors: Mariam S Aboian; Cassie N Kline; Yi Li; David A Solomon; Erin Felton; Anu Banerjee; Steve E Braunstein; Sabine Mueller; William P Dillon; Soonmee Cha Journal: Neurooncol Pract Date: 2018-02-17
Authors: L Liebsch; S Kailayangiri; L Beck; B Altvater; R Koch; C Dierkes; M Hotfilder; N Nagelmann; C Faber; H Kooijman; J Ring; V Vieth; C Rossig Journal: Br J Cancer Date: 2013-07-09 Impact factor: 7.640
Authors: Daniel Rodriguez Gutierrez; Muftah Manita; Tim Jaspan; Robert A Dineen; Richard G Grundy; Dorothee P Auer Journal: Neuro Oncol Date: 2013-04-12 Impact factor: 12.300